- Issuer ticker
-
BBNX
- Reported as of
-
21 May 2026
- Net transaction value
-
-$21,138
- SEC form
-
4
- Accepted by SEC
-
26 May 2026, 18:00:27 UTC
Filing notes and source
Key filing fact
Adam Lezack filed Form 4 for Beta Bionics, Inc. (BBNX) on 26 May 2026.
Key facts
- This page summarizes Adam Lezack's Form 4 filing for Beta Bionics, Inc. (BBNX).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 May 2026, 18:00.
Change
- Previous filing in this sequence was filed on 14 Jan 2026.
- Current net transaction value: -$21,138.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002048466
Primary reporting owner
Lezack Adam
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BBNX
transaction
Common Stock
Sale
- Transaction value
- -$9,950
- Shares
- -1,000
- Change %
- -8%
- Price
-
$9.95
- Shares after
- 11,432
- Date
- 21 May 2026
- Ownership
- Direct
- Footnotes
- F1
BBNX
transaction
Common Stock
Award
- Transaction value
- Shares
- +16,965
- Change %
- +148%
- Price
-
$0.000000*
- Shares after
- 28,397
- Date
- 21 May 2026
- Ownership
- Direct
- Footnotes
- F2
BBNX
transaction
Comon Stock
Sale
- Transaction value
- -$11,188
- Shares
- -998
- Change %
- -3.5%
- Price
-
$11.21
- Shares after
- 27,399
- Date
- 22 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses
2 footnotes